In a recent publication of Atlanta Medicine Magazine Vol.2, 2021, Charmaine Emelife, MD, Senior Partner of SouthEast Kidney Associates, has been featured as a Guest Editor at Renal Medicine 2021 Issue- Journal of Medicine Association of Atlanta.
In the published article, she talks about how Hypertension (HTN) and Chronic Kidney Disease (CKD) are intertwined in their pathophysiology and are often closely occurring. Starting with the history of nephrology she talked about how earlier kidney patients were diagnosed and treated.
She talks about guidelines on Hypertension (HTN) from the American College of Cardiology/ American Heart Association (ACC/ AHA) and common pathophysiology of HTN leading to Chronic Kidney Disease/ End-Stage Renal Disease (CKD/ ESRD)
Dr. Charmain Emelife covered the causes of HTN and highlights the following:
Hypertension has been shown to run in families. In addition, she also talks about environmental factors complicating the occurrence of HTN, especially lifestyle behaviors such as alcohol consumption, smoking poor diet and obesity.
She also highlights that sustained hypertension, white-coat hypertension (found in 10-20% of CKD patients) and masked hypertension (found in 10-30% of CKD patients) have all been associated with an increased risk of death; the strongest association was found with masked hypertension. Multiple approaches to possible mechanisms of hypertension in chronic kidney disease have evolved over the years.
Along with covering various factor, Dr. Emlife also discussed how one can manage HTN which begins with lifestyle modifications and pharmacotherapy often starting with an ACE inhibitor, angiotensin-receptor blocker, calcium-channel blocker, or thiazide diuretic.
She also highlighted African American study of Kidney Disease and Hypertension (AASK), wherein black patients with hypertensive chronic kidney disease showed no effect of blood-pressure control on kidney disease progression.
In reference to the latest development on SGLT2 inhibitors, she talked about prevention, which has shown to be effective in reducing risk for adverse cardiovascular and kidney disease outcomes. She concludes that it is important that the healthcare professional continuously focus on HTN control for patients with CKD as per recommended guidelines by ACC/AHA.
Read the full article here – https://www.mdatl.com/past-issues/
About Dr. Charmaine Emelife- Dr. Emelife has a master’s degree in Health Administration from the Milken’s Institute of Public Health, George Washington University and is a member of Wellstar WCP/ACO Board. She is a fellow of the American Society of Nephrology. Dr. Emelife earned her MBBS at the University of Nigeria, College of Medicine. She received training in Internal Medicine at John Stroger Cook Country Hospital, Chicago and a fellowship in Nephrology at Loyola University Hospital and the Hines VA hospital in Maywood Illinois. She has practiced nephrology for 24 years now.
About Atlanta Medicine Magazine- Atlanta Medicine is a medical journal dedicated to providing physician-contributed articles and local healthcare information to more than 4,000 physicians in metro Atlanta.
© Copyright 2024 Southeast Kidney Associates | All Rights Reserved by Panoramic Health
